Thu. 2 May 2024, 8:06am ET
Benzinga
Earnings, Earnings Misses, News
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.95) by 2.11 percent. This is a 21.25 percent decrease over losses of $(0.80) per share from the same period last year.